Breast cancer is commonly categorized by hormone receptor expression and can be classified into distinct groups: estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-positive (HER2+), progesterone receptor-positive (PR+), or triple-negative breast cancer (TNBC) [75]. This evidence concerns the gene PGR and breast carcinoma.